Diuretic therapy in fluid-overloaded and heart failure patients

Contributions to Nephrology

Volumn 164, Issue , 2010, Pages 153-163

  Bellomo, Rinaldo ^a   Prowle, John R ^a   Echeverri, Jorge E ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

AGED; CASE REPORT; HEART FAILURE; HUMAN; MALE; METABOLIC DISORDER; PERICARDIAL EFFUSION; PLEURA EFFUSION; POSTOPERATIVE HEMORRHAGE; REVIEW; RHEUMATIC HEART DISEASE;

AGED; DIURETICS; HEART FAILURE; HUMANS; MALE; PERICARDIAL EFFUSION; PLEURAL EFFUSION; POSTOPERATIVE HEMORRHAGE; RHEUMATIC HEART DISEASE; WATER-ELECTROLYTE IMBALANCE;

EID: 77955483307     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000313728     Document Type: Article

References (26)

1. Androne AS, Hryniewicz K, Hudaihed A, et al: Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 2004;93:1254-1259.
2. Damman K, van Deursen VM, Navis G, et al: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-588.
3. Mullens W, Abrahams Z, Francis GS, et al: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589-596.
4. Drazner MH, Rame JE, Stevenson LW, et al: Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574-581.
5. Packer M: The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-254.
6. Marenzi G, Lauri G, Grazi M, et al: Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001;38:963-968.
7. Bart BA, Boyle A, Bank AJ, et al: Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid overloaded Patients with Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005;46:2043-2046.
8. Costanzo MR, Guglin ME, Saltzberg MT, et al: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683.
9. Bellomo R, Uchino S: Cardiovascular monitoring tools: use and misuse. Curr Opin Crit Care 2003;9:225-229.
10. Martin SJ, Danziger LH: Continuous infusion of loop diuretics in the critically ill: a review of the literature. Crit Care Med 1994;22:1323-1329.
11. Pitt B, Zannad F, Remme W Y J, et al: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.
12. Schetz M: Loop diuretics; in Ronco C, Bellomo R, Kellum JA (eds): Critical Care Nephrology. Philadelphia, Saunders-Elsevier, 2009, pp 547-551.
13. Warrillow S: Carbonic anhydrase inhibitors; in Ronco C, Bellomo R, Kellum JA (eds): Critical Care Nephrology. Philadelphia, Saunders-Elsevier, 2009, pp 566-568.
14. Hughes AD: Thiazide diuretics; in Ronco C, Bellomo R, Kellum JA (eds): Critical Care Nephrology. Philadelphia, Saunders-Elsevier, 2009, pp 555-561.
15. Felker GM, O'Connor CM, Braunwald E: Loop diuretics in acute decompensated heart failure: Necessary Evil? A necessary evil? Circ Heart Fail 2009;2:56-62.
16. Wang DJ, Gottlieb SS: Diuretics: still the mainstay of treatment. Crit Care Med 2008;36(suppl 1): S89-S94.
17. Abraham WT, Lowes BD, Ferguson DA, et al: Systemic, hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamic decompensated hear failure. J Card Fail 1998;4:37-44.
18. Witteles RM, Kao D, Christopherson D, et al: Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 2007;50:1835-1840.
19. Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005;29:1487-1491.
20. Sackner-Bernstein JD, Kowalski M, Fox M, et al: Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005;293:1900-1905.
21. Ronco C, Haapio M, House AA, et al: Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
22. Jose P, Skali H, Anavekar N, et al: Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006;17:2886-2891.
23. Heywood JT, Fonarow GC, Costanzo MR, et al: High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007;13:422-430.
24. Hasselblad V, Gattis Stough W, Shah MR, et al: Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Failure 2007;9:1064-1069.
25. Schrier R: Role of Diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006;47:1-8.
26. Pfisterer M, Buser P, Rickli H, et al: BNPguided vs. symptom-guided heart failure therapy: the trial of intensified vs. standard medical therapy in elderly patients with congestive heart failure randomized trial. JAMA 2009;301:383-392.